A detailed history of Silvercrest Asset Management Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 1,208,827 shares of ABT stock, worth $155 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
1,208,827
Previous 1,237,988 2.36%
Holding current value
$155 Million
Previous $129 Million 7.14%
% of portfolio
0.96%
Previous 0.94%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $2.92 Million - $3.44 Million
-29,161 Reduced 2.36%
1,208,827 $138 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $125 Million - $139 Million
-1,237,988 Reduced 50.0%
1,237,988 $129 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $121 Million - $135 Million
1,202,885 Added 94.49%
2,475,976 $257 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $4.56 Million - $5.04 Million
-41,670 Reduced 3.17%
1,273,091 $145 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $5.68 Million - $6.95 Million
-62,988 Reduced 4.57%
1,314,761 $145 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $4.06 Million - $4.87 Million
-42,508 Reduced 2.99%
1,377,749 $133 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $11.4 Million - $12.7 Million
113,411 Added 8.68%
1,420,257 $155 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $2.7 Million - $3.18 Million
27,874 Added 2.18%
1,306,846 $132 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $25 Million - $29.4 Million
263,360 Added 25.93%
1,278,972 $140 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $2.84 Million - $3.29 Million
-29,366 Reduced 2.81%
1,015,612 $98.3 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $1.29 Million - $1.56 Million
-12,627 Reduced 1.19%
1,044,978 $114 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $16.4 Million - $20 Million
-143,870 Reduced 11.97%
1,057,605 $125 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $398,116 - $487,471
-3,446 Reduced 0.29%
1,201,475 $169 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $3.22 Million - $3.56 Million
-27,586 Reduced 2.24%
1,204,921 $142 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $29.2 Million - $34.4 Million
-275,961 Reduced 18.29%
1,232,507 $143 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $1.11 Million - $1.31 Million
10,187 Added 0.68%
1,508,468 $181 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $147,210 - $160,416
-1,402 Reduced 0.09%
1,498,281 $164 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $1.76 Million - $2.14 Million
-19,233 Reduced 1.27%
1,499,683 $163 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $17.6 Million - $22.5 Million
-229,920 Reduced 13.15%
1,518,916 $139 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $2.45 Million - $3.58 Million
-38,956 Reduced 2.18%
1,748,836 $138 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $362,951 - $404,050
4,623 Added 0.26%
1,787,792 $155 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $279,319 - $302,869
-3,413 Reduced 0.19%
1,783,169 $149 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $191,382 - $223,210
2,626 Added 0.15%
1,786,582 $150 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $1.08 Million - $1.3 Million
-16,281 Reduced 0.9%
1,783,956 $143 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $32 Million - $36.3 Million
-488,157 Reduced 21.33%
1,800,237 $130 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $12,344 - $14,892
203 Added 0.01%
2,288,394 $168 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $5.84 Million - $6.45 Million
-101,496 Reduced 4.25%
2,288,191 $140 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $874,829 - $989,100
-15,547 Reduced 0.65%
2,389,687 $143 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $430,674 - $461,081
8,023 Added 0.33%
2,405,234 $137 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $115 Million - $129 Million
2,397,211
2,397,211 $128 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.